Quinolinium, 1-(carboxymethyl)-4-[2-[4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydrocyclopent[b]indol-7-yl]ethenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)


List details

Basic info

Status Opinions adopted
Details on the scope of restriction The proposal intends to restrict the manufacture, use and placing on the market of PFHxS, its salts and related substances as substances, constituents of other substances, mixtures and articles or parts thereof.
Reason for restriction PFHxS is a substance of very high concern due to its very persistent and very bioaccumulating properties. PFHxS-related substances degrade to PFHxS. The substance is found in high levels in the environment, and studies indicate increasing concentrations in the environment and in human blood serum. Norway has submitted a proposal to list PFHxS, its salts and PFHxS-related compounds in Annexes A, B and/or C to the Stockholm Convention on Persistent Organic Pollutants.

Intention timeline

Date of intention 2018-04-12
Expected date of submission 2019-04-12
Latest update 2020-12-10

Support information

Restriction report and annexes

Related substances

No substances related to this record were found in our database.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
Dec. 10, 2020
  • Latest update: 2020-11-112020-12-10
Nov. 30, 2020
  • Latest update: 2020-06-022020-11-11
  • Status: Opinion developmentOpinions adopted
June 2, 2020
  • Latest update: 2020-03-312020-06-02